All news

Lonza launches insect medium enabling increased AAV production

24-Mar-2020 By Vassia Barba

Designed specifically for AAVs production to support gene therapies, a medium launched by Lonza is expected to accelerate cell growth while saving developers time and costs.

Insulin designated biologic in ‘landmark moment’

24-Mar-2020 By Ben Hargreaves

Manufacturers can now apply to the US FDA for the approval of biosimilars to insulin products.

Routine continuous bioprocessing up to ten years away

23-Mar-2020 By Ben Hargreaves

A report claims that despite significant interest in implementing continuous bioprocesses, fully continuous systems are five to 10 years away from widespread adoption.

Bristol Myers turns to Oxford Biomedica for CAR-T manufacturing

20-Mar-2020 By Vassia Barba

Oxford Biomedica set to receive up to $96m to support the development of Juno’s CAR-T therapies.

CGTC in ‘third phase’ expansion of cell and gene manufacturing site

20-Mar-2020 By Ben Hargreaves

CGTC will add seven laboratories to its manufacture site in the UK, with most of the work taking place off-site.

Univercells spins out viral vector CDMO to meet capacity demands

20-Mar-2020 By Vassia Barba

Univercells announces the launch of Exothera, a CDMO focusing on viral vectors to support cell and gene therapy developers.

Roche’s treatment for coronavirus enters Phase III

19-Mar-2020 By Ben Hargreaves

Roche looks to repurpose its arthritis medicine for use against the coronavirus, after China previously endorsed its use.

Pharma events update: rescheduled, canceled, online

18-Mar-2020 By Jenni Spinner

This list includes the industry events that have been postponed or moved because of the coronavirus pandemic.

Fujifilm Diosynth to create biocampus in the UK

18-Mar-2020 By Vassia Barba

Fujifilm Diosynth announced plans to build a research center in the UK to answer growing demand in services for biologics, vaccines, and gene therapies development.